Latest news
Lymphoma Tech Meeting: Seminar by Ralf Küppers
We are delighted to announce the next seminar in the Lymphoma Tech Meetings exclusively tailored to early career researchers within the SFB 1530.
T…
SFB 1530 Double Feature: Talk by Ulrike Köhl + Lymphoma Tech Meeting
Ulrike Köhl is professor of immunoncology and the director of both the Institute for Clinical Immunology at the University of Leipzig and the…
Selection of latest publications
Read the newest papers from the first half of 2024
SFB 1530 Double Feature: Talk by Prof. Sebastian Kobold + Diversity Coffee Break
Sebastian Kobold is Professor of Medicine and Experimental Immunooncology at the University Hospital of the LMU and a board certified immunologist and…
Diversity Coffee Break: First Generation Doctorate Mentoring+
Time to take a coffee break again ☕. Following the Diversity Week at the University of Cologne June 3rd-7th, we are happy to reintroduce our SFB 1530…
SFB 1530 Seminar Series: Florian Bassermann
Florian Bassermann is the director of the department of hematology and oncology at the University Hospital Klinikum Rechts der Isar in Munich and…
The Lymphoma Tech Meetings are here!
Register for our kick-off seminar on 4 June 2024
Women & Science: Advancing Cancer Research - Elisa ten Hacken
Join our first seminar in the Women & Science series
Seminar: Early Career Researchers in Oncology - funding opportunities
Date: Wednesday, May 7 2024, 10:00 am - 12:00 pm
Location: University Hospital of Cologne, Kerpenerstr. 62, 50937 Köln, CIO (building 70), seminar…
SFB 1530 Seminar Series: Michael Hudecek
Our next seminar will be held by Michael Hudecek, chair of the Department for Cellular Immunotherapy at the University Hospital of Würzburg. The Hudec…
Latest news
CRC 1530 Coffee Break ☕ with Kristie Bariboloka
Anh Thu: Hi Kristie, could you introduce yourself and share some details about…
CRC 1530 Seminar Series: Heinz Jacobs, PhD
We are excited to announce our next CRC 1530 seminar featuring Prof. Heinz…
CRC 1530 Coffee Break ☕ with Mila Daoud
K: Hi Mila, please introduce yourself, and tell us about your scientific…